Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962390 | Vaccine | 2016 | 6 Pages |
Abstract
This commentary examines the 2014 NIPH evaluation of Gavi's co-financing policy and comments on the appropriateness of the subsequent and most significant policy changes taking effect in 2016.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Klara Henderson, Dimitrios Gouglas, Laura Craw,